TickerLeague

Stock-Based Compensation for McKesson (MCK)

Stock-Based Compensation for McKesson (MCK): headline value $0. Annual and quarterly series, chart, and tables are below.

Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .

Latest period

$0

YoY change

N/A

5Y CAGR

N/A

Peak year (2015)

$174.00M

Latest annual

$0

Stock-Based Compensation history chart for McKesson (MCK) from 1995 to 2025

Stock-Based Compensation history table for McKesson (MCK) from 1995 to 2025

Fiscal yearPeriod endedReportedStock-Based CompensationYoY
2025$0
2024$0-100.0%
2023$162.00M+0.6%
2022$161.00M
2021$0
2020$0
2019$0-100.0%
2018$69.00M-40.0%
2017$115.00M-6.5%
2016$123.00M-29.3%
2015$174.00M+8.8%
2014$160.00M-4.2%
2013$167.00M+8.4%
2012$154.00M+12.4%
2011$137.00M+20.2%
2010$114.00M+15.2%
2009$99.00M+8.8%
2008$91.00M
2007$0
2006$0
2005$0
2004$0
2003$0
2002$0
2001$0
2000$0
1999$0
1998$0
1997$0
1996$0
1995$0

Stock-Based Compensation values are taken from McKesson's reported cash flow statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.

Analysis

McKesson (MCK) most recent annual stock-based compensation stands at $0 (2025).

Over 2015–2025 (10 years), McKesson stock-based compensation expanded at a -100.0% compound annual rate, with a net decline across the window.

2015 marks the peak stock-based compensation at $174.00M, with the historical low of $0 recorded in 1995.

McKesson (MCK) sits 5th of 8 Healthcare peers we track on this metric, against a peer median of $313.00M.

McKesson Stock-Based Compensation by Year

McKesson Stock-Based Compensation 2025: $0

McKesson stock-based compensation in 2025 was $0.

McKesson Stock-Based Compensation 2024: $0

McKesson stock-based compensation in 2024 was $0, plunged 100.0% below 2023.

McKesson Stock-Based Compensation 2023: $162.00M

McKesson stock-based compensation in 2023 was $162.00M, edged up 0.6% from 2022.

McKesson Stock-Based Compensation 2022: $161.00M

McKesson stock-based compensation in 2022 was $161.00M.

McKesson Stock-Based Compensation 2021: $0

McKesson stock-based compensation in 2021 was $0.

See more financial history for McKesson (MCK).

Sector peers — Stock-Based Compensation

Companies in the same sector as McKesson, ranked by their latest stock-based compensation.

CompanyStock-Based CompensationSector
Johnson & Johnson (JNJ)$1.35BHealthcare
UnitedHealth Group Incorporated (UNH)$971.00MHealthcare
AbbVie Inc. (ABBV)$955.00MHealthcare
Eli Lilly and Company (LLY)$626.00MHealthcare
AstraZeneca PLC (AZN)$0Healthcare
Merck & Co., Inc. (MRK)$0Healthcare
Amgen Inc. (AMGN)$0Healthcare
Novo Nordisk A/S (NVO)$0Healthcare

Frequently asked questions

What is McKesson's stock-based compensation?

Latest reported stock-based compensation for McKesson (MCK) is $0 (period ending December 31, 2025).

What is the long-term growth rate of McKesson stock-based compensation?

McKesson (MCK) stock-based compensation compound annual growth rate is -100.0% over the most recent 10 years available.

When did McKesson stock-based compensation hit its highest annual value?

McKesson stock-based compensation reached its highest annual value of $174.00M in 2015.

What was McKesson stock-based compensation in 2024?

McKesson (MCK) stock-based compensation in 2024 was $0.

What was McKesson stock-based compensation in 2025?

McKesson (MCK) stock-based compensation in 2025 was $0.

Metrics overview

Pick a metric for charts, filings and peers — each row shows the latest TTM or most-recent-quarter value.